Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Company
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Number of employees : 15 455 people.
Sales per Business
20202021Delta
Pharmaceutical1 300 840.00100%1 249 530.00100% -3.94%
JPY in Million
Sales per region
20202021Delta
United States443 455.0034.1%473 190.0037.9% +6.71%
Established Markets296 103.0022.8%293 156.0023.5% -1%
Japan345 402.0026.6%279 130.0022.3% -19.19%
International134 792.0010.4%111 113.008.9% -17.57%
Greater China60 367.004.6%59 300.004.7% -1.77%
Other20 725.001.6%33 639.002.7% +62.31%
JPY in Million
Managers
Name Title Age Since
Kenji Yasukawa President, CEO & Representative Director 61 2018
Naoki Okamura Representative Director, VP & Head-Finance 58 2019
Yoshitsugu Shitaka Chief Scientific Officer - -
Fumiaki Sakurai Head-Business Administration & Compliance - -
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 65 2019
Nobue Yasuda Manager-Accounting - -
Nobuaki Tanaka Senior Executive Officer & General Manager-Sales 54 -
Claudia Mitchell, Dr. Senior VP-Product & Portfolio Strategy - 2019
Members of the board
Name Title Age Since
Yoshihiko Hatanaka Chairman 64 2018
Kenji Yasukawa President, CEO & Representative Director 61 2018
Naoki Okamura Representative Director, VP & Head-Finance 58 2019
Tomokazu Fujisawa Director 63 2018
Hiroko Sakai Director 60 2018
Noriyuki Uematsu Outside Director 61 2018
Hiroo Sasaki Outside Director 65 2018
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 65 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 1,861,787,075 1,842,077,201 98.9% 8,935,909 0.5% 98.9%
Shareholders
NameEquities%
Nomura Asset Management Co., Ltd. 112,101,000 6.02%
Wellington Management Co. LLP 68,376,779 3.67%
Nippon Life Insurance Co. 64,486,000 3.46%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 63,322,700 3.40%
Nikko Asset Management Co., Ltd. 60,908,600 3.27%
BlackRock Fund Advisors 60,791,229 3.27%
Daiwa Asset Management Co. Ltd. 53,328,893 2.86%
The Vanguard Group, Inc. 47,852,760 2.57%
Norges Bank Investment Management 30,885,860 1.66%
BlackRock Japan Co., Ltd. 28,854,100 1.55%
Holdings
NameEquities%Valuation
CYTOKINETICS, INCORPORATED (CYTK) 2,040,816 2.44% 67,285,704 USD
FIBROGEN, INC. (FGEN) 4,968,367 5.36% 57,782,108 USD
ASTELLAS PHARMA INC. (4503) 1,083,700 0.058% 18,318,139 USD
ONCOLYS BIOPHARMA INC. (4588) 727,200 4.19% 8,406,556 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 1,199,819 4.92% 7,863,374 USD
BRICKELL BIOTECH, INC. (BBI) 12,303 0.014% 9,080 USD
Markets and indexes
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- Bloomberg Code :  4503:JP
- Reuters Code :  4503.T
- Datastream Code :  
Company contact information
Astellas Pharma Inc.
2-5-1 Nihonbashi-Honcho
JP-103-8411 Chuo-ku, Tokyo

Phone : +81 3 3244 3000
Fax :
web site : http://www.astellas.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Astellas Pharma Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ASTELLAS PHARMA INC.18.51%31 807
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.21.62%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.84%209 456
ABBVIE INC.0.87%190 996
NOVARTIS AG-6.89%188 323
MERCK & CO., INC.-12.02%182 183
ASTRAZENECA PLC11.16%173 735
BRISTOL-MYERS SQUIBB COMPANY-1.29%136 060
AMGEN INC.-5.46%123 428
SANOFI3.77%120 604
GLAXOSMITHKLINE PLC3.95%96 182
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%61 871
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 198
BAYER AG-5.22%52 750
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 385
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%45 545
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY47.57%24 385